semaglutide peak plasma Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials | Clinical Pharmacokinetics Semaglutide, a Once-Weekly Human GLP-1

The primary objective was to demonstrate superiority of semaglutide 7.2 mg against placebo on weight loss after 72 weeks with respect to the percentage change in body weight and the proportion of participants achieving weight loss of 5% or greater

Distinguishing Semaglutide-Induced Bloating To determine if semaglutide is causing your bloating, consider the timing of the symptoms

Eat and drink slowly

If taste disturbances become bothersome, your provider can lower your injection dose, pause escalation, or consider alternative formulations (such as oral semaglutide at $289/mo (or $249/mo on the 6-month plan) or microdose GLP-1 protocols at $129/mo) that some patients tolerate better